The startup has emerged from stealth with $77.6m from backers including Boehringer Ingelheim to advance four potential cancer treatments into the clinic.

Tencent returned to help the AI drug discovery platform hike its overall funding to $174m with a round that will support hiring and technology development.

T-Knife has emerged from stealth with $77.6m in series A funding to advance four potential cancer treatments into the clinic and open a US office.

Genome and Company has acquired a majority stake in Scioto Biosciences following its contribution to a series B round that will be sized at up to $26.5m.

Utec has backed immunotherapy screening business ImmunoScape, which hopes to launch its product in the US and Japan.

The cancer treatment developer floated in the middle of its range following $175m in venture funding from investors including Novo.

YJ Capital and existing investor GV were among the partcipants in the latest round for metabolic disease treatment developer Fractyl.

Sinopharm Capital contributed to a series A-plus round raised two months after ABM began enrolling patients for a phase 1 trial of its cancer drug candidate.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The Müller Medien-backed telehealth diagnostics system developer raised $10.3m in a round co-led by Heal Capital and the European Bank for Reconstruction and Development.